In this 2012 leaflet, Dr Charles Shepherd weighs up for the evidence for using the anti-lymphoma drug, rituximab, as a treatment for ME/CFS.
A year earlier, a Norwegian group had published the results of a clinical trial which had assessed the use of rituximab in treating a small group of people with ME/CFS. The trial had encouraging results – certainly in a group of people who had a form of immune dysfunction as part of their illness. The results now need to be assessed in further clinical trials before any conclusions can be drawn. This Management File looks at the drug in detail and discusses the results of the Norwegian clinical trial.
- Product Options
# Option Price 1 Digital download UK & Europe £1 inc VAT £0.83 2 Digital download Rest of World £1 £1.00